A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
Clinical trial NCT07277231 · RECRUITING
Trial details
- NCT number
- NCT07277231
- Sponsor
- BeOne Medicines
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-22
- Primary completion
- 2031-02-01
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.